You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial
|
---|---|
Published in |
Annals of the Rheumatic Diseases, December 2014
|
DOI | 10.1136/annrheumdis-2014-205698 |
Pubmed ID | |
Authors |
Alf Kastbom, Kristina Forslind, Sofia Ernestam, Pierre Geborek, Johan A Karlsson, Ingemar F Petersson, Saedis Saevarsdottir, Lars Klareskog, Ronald F van Vollenhoven, Karin Lundberg |
Abstract |
To determine the relationship between changes in antibody levels towards citrullinated peptides derived from different candidate autoantigens and therapeutic outcome in early rheumatoid arthritis (RA). |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Turkey | 1 | 25% |
United Kingdom | 1 | 25% |
United States | 1 | 25% |
India | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 2 | 50% |
Members of the public | 2 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 1% |
Netherlands | 1 | 1% |
Germany | 1 | 1% |
Canada | 1 | 1% |
Unknown | 83 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 17 | 20% |
Student > Ph. D. Student | 11 | 13% |
Student > Bachelor | 10 | 11% |
Professor | 6 | 7% |
Student > Master | 6 | 7% |
Other | 18 | 21% |
Unknown | 19 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 38 | 44% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 8% |
Immunology and Microbiology | 5 | 6% |
Biochemistry, Genetics and Molecular Biology | 4 | 5% |
Agricultural and Biological Sciences | 2 | 2% |
Other | 8 | 9% |
Unknown | 23 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2016.
All research outputs
#2,750,802
of 22,776,824 outputs
Outputs from Annals of the Rheumatic Diseases
#1,667
of 7,199 outputs
Outputs of similar age
#40,514
of 352,738 outputs
Outputs of similar age from Annals of the Rheumatic Diseases
#25
of 73 outputs
Altmetric has tracked 22,776,824 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,199 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.0. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,738 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.